CNBC September 20, 2023
Stefan Sykes

Key Points

– Tobacco giant Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.

– The company has been making inroads into the wellness and health-care space in recent years as it pivots toward becoming a business focused on smoke-free products and respiratory medicines.

– More recently, the division has struggled, and Philip Morris has had talks with Deutsche Bank on a range of options to try to grow its wellness and health-care division.

Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.

The tobacco company, which makes Marlboro cigarettes, made inroads into the health care and wellness space in 2021 with the acquisition of Vectura, a U.K.-based pharmaceutical company...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Provider, Trends, Wellness
What to know about real estate wellness—the fastest-growing market in the $5.6 trillion global wellness industry
When It Comes to Preventive and Proactive Wellness, Accessibility Is Key
Safeguarding The Well-Being Of The Health Care Workforce: The Evolving Role Of Chief Wellness Officers
Private Equity Firms Considering Buyout of Peloton
Integrated Health Metrics Unlock New Frontier for Connected Wellness

Share This Article